Related Articles
Efficacy of vonoprazan for 24-week maintenance therapy of patients with healed reflux esophagitis refractory to proton pump inhibitors
Vonoprazan 10 mg daily is effective for the treatment of patients with proton pump inhibitor‑resistant gastroesophageal reflux disease
Upper gastrointestinal involvement in systemic sclerosis: Findings in a real‑life setting
Long‑term vonoprazan therapy is effective for controlling symptomatic proton pump inhibitor‑resistant gastroesophageal reflux disease
Association between bile area in the duodenal bulb and abdominal symptoms: Quantitative analysis using blue laser imaging